Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Sales | 7,154,000 | 6,516,000 | 6,625,000 | 6,180,000 | 6,286,000 |
| Cost of Goods | 1,578,000 | 1,339,000 | 1,391,000 | 1,251,000 | 1,338,000 |
| Gross Profit | 5,576,000 | 5,177,000 | 5,234,000 | 4,929,000 | 4,948,000 |
| Operating Expenses | 4,257,000 | 3,195,000 | 3,303,000 | 3,030,000 | 3,382,000 |
| Operating Income | 1,319,000 | 1,982,000 | 1,931,000 | 1,899,000 | 1,566,000 |
| Interest Expense | 0 | 0 | 0 | 0 | -286,000 |
| Other Income | 784,000 | 205,000 | 278,000 | 145,000 | -163,000 |
| Pre-tax Income | 2,103,000 | 2,187,000 | 2,209,000 | 2,044,000 | 1,689,000 |
| Income Tax | 658,000 | 595,000 | 607,000 | 620,000 | 462,000 |
| Net Income Continuous | 1,445,000 | 1,592,000 | 1,602,000 | 1,424,000 | 1,227,000 |
| Net Income | $1,445,000 | $1,592,000 | $1,602,000 | $1,424,000 | $1,227,000 |
| EPS Basic Total Ops | 0.47 | 0.51 | 0.51 | 0.45 | 0.39 |
| EPS Basic Continuous Ops | 0.47 | 0.51 | 0.51 | 0.45 | 0.39 |
| EPS Diluted Total Ops | 0.47 | 0.51 | 0.51 | 0.45 | 0.39 |
| EPS Diluted Continuous Ops | 0.47 | 0.51 | 0.51 | 0.45 | 0.39 |
| EBITDA(a) | $1,747,000 | $2,311,000 | $2,237,000 | $2,181,000 | $1,960,000 |